Today, China New Pharmaceutical opened at 17.4 yuan. As of 10:55 points, the stock rose 10% to 19.25 yuan, closing the daily limit. The company is mainly engaged in the production and sales of traditional Chinese medicine, chemical medicine and bioengineering drugs.

Financial World Website reported on June 17 that , China New Pharmaceutical opened at 17.4 yuan. As of 10:55, the stock rose 10% to 19.25 yuan, blocking the daily limit.

Yesterday (2020-06-16), the net inflow of the stock was 9.5757 million yuan, the main force was 9.9399 million yuan, the net outflow of the mid-select was 5,599 yuan, and the net outflow of retail investors was 358,600 yuan.

In the past month, Zhongxin Pharmaceutical has been on the Dragon and Tiger List 0 times, indicating that Zhongxin Pharmaceutical is not active.

Company is mainly engaged in the production and sales of traditional Chinese medicine, chemical drugs, and bioengineering drugs. As of March 31, 2020, China New Pharmaceutical 's operating income was 1.65596 billion yuan, and the net profit attributable to the parent company's shareholders was 16989 million yuan, a decrease of 10.5876% year-on-year, and basic earnings per share was 0.221 yuan.

Risk warning: The individual stock diagnostic results are produced by processing objective data through operational models. They are for reference only and do not constitute absolute investment advice.